Безопасен ли hydrogenated bisabolol при беременности?
No harmonised CLP reproductive classification (ECHA Annex VI) or SCCS/CIR repro warnings for hydrogenated bisabolol were identified. CIR assessments and SCCS opinions cover bisabolol/related cosmetic use and conclude safety 'as used' for topical applications; peer‑reviewed literature (PubMed) does not report teratogenic or reproductive effects for hydrogenated bisabolol. Therefore default hazard/mechanism scores are 0 and dermal exposure from normal cosmetic use is considered negligible (evidence: CIR; SCCS where applicable; PubMed; ECHA Annex VI).
Related ingredients
Frequently asked questions
- Безопасен ли hydrogenated bisabolol при беременности?
- No harmonised CLP reproductive classification (ECHA Annex VI) or SCCS/CIR repro warnings for hydrogenated bisabolol were identified. CIR assessments and SCCS opinions cover bisabolol/related cosmetic use and conclude safety 'as used' for topical applications; peer‑reviewed literature (PubMed) does not report teratogenic or reproductive effects for hydrogenated bisabolol. Therefore default hazard/mechanism scores are 0 and dermal exposure from normal cosmetic use is considered negligible (evidence: CIR; SCCS where applicable; PubMed; ECHA Annex VI).
- Безопасен ли hydrogenated bisabolol при грудном вскармливании?
- No data indicating reproductive or lactation hazards, no harmonised classification, and no studies showing transfer into breastmilk. With topical cosmetic use the expected systemic exposure is negligible; therefore hazard and mechanism scores are 0 and exposure scored as negligible (sources: CIR/SCCS coverage of bisabolol class, PubMed, ECHA Annex VI, PubChem/CosIng listings).
- Безопасен ли hydrogenated bisabolol для кожи малыша?
- No infant‑specific reproductive or toxicity data found and no harmonised flags; hazard and mechanism remain 0. Per guidance, exposure for 0–3 yr skin is increased by +1 relative to adults because infant skin has greater absorption and surface‑area/weight, so exposure scored 1. Safety as used in cosmetics is supported by CIR/SCCS discussion of bisabolol derivatives; no infant‑specific adverse reports located (sources: CIR, SCCS/preferred opinions for bisabolol class; PubMed; CosIng; EWG).
- Как VeriMom оценивает hydrogenated bisabolol?
- VeriMom оценивает hydrogenated bisabolol в 100/100 (без известных рисков) на основе EU CosIng, классификаций ECHA и исследований PubMed.
- Какие безопасные альтернативы hydrogenated bisabolol при беременности?
- См. наш список безопасных альтернатив hydrogenated bisabolol с аналогичной функцией и классификацией без известных рисков.
Проверь любой состав за 2 секунды
Скачай VeriMom бесплатно — отсканируй любой продукт и мгновенно получи оценку безопасности при беременности.
Медицинская оговорка
Данная информация предоставлена исключительно в образовательных целях и не является медицинской рекомендацией. Оценки безопасности основаны на общедоступных данных и могут не отражать все риски. Всегда консультируйтесь с вашим врачом перед использованием любых средств во время беременности или грудного вскармливания.